Bioengineered drugs likely to provide the long-sought answer to curing neurodegenerative illnesses explain Internet Marketing Expert “Chad Lieberman”.

NEW YORK, NEW YORK, USA, September 28, 2015 /EINPresswire.com/ -- “Advances in biotechnology and bioengineering have made the greatest difference in the healthcare sector. Thanks to continued research, we stand a better chance today at curing the world’s non-curable diseases including HIV, Parkinson’s disease and Alzheimer’s. And the future looks even more promising.”

These were Internet marketing expert, futurist and technology enthusiast New York City Chad Ian Lieberman’s opening remarks at a discussion he held recently to discuss the current and future technologies changing healthcare systems in the world. The meet up took place at his business premises in Manhattan, and featured guests from all over the state.

“Biotechnology drugs are made from living cells, and to date give us the best chance of curing diseases like Alzheimer’s, diabetes, HIV and Parkinson’s. A short while back, the FDA approved a drug made from cells extracted from bioengineered goats to treat a rare blood clotting disease. This is a big step for us in the fight.”

Mr. Chad Lieberman was excited to note that presently, more than 630 new bioengineered drugs were at various phases of the drug research process, meaning that the future looks bright. He described Alzheimer’s as a neurodegenerative disorder that starts in old age and worsens over time, eventually causing patient death.

“It has been linked to accumulation of plaque around nerve cells leading to impaired neural connections. Today, this plaque can be removed from the brain non-invasively using ultrasound therapy,” Chad explained.

He described this as being a step ahead given that all past pharmaceutical treatments were rather strong and invasive, yet they were no more effective than slowing down the progress of the disease for a time.

“While research for both bioengineered drugs and non-pharmacological solutions are still in the clinical trial phases, we can expect to finally cut into the core of this disease and treat its root cause, instead of using therapies that merely treat symptoms and slow down neuron-degeneration.”

Long discussions were held in consultation with experts concerning the subject, and the session ended on a positive note from Mr. Chad Ian Lieberman, who expressed great eagerness for the development of technologies to cure diseases that have until now remained incurable, and that in the next two years or so.

About Chad Lieberman – New York – 6W

Chad Ian Lieberman is one of the best Internet Marketers in the United States at 6W. Presently, Chad Ian oversees all business development, project management and customer service, including running the day-to-day operations of 6W New York City.

Chad has been experimenting, researching and implementing digital marketing strategies since 1999. He received his Bachelor’s degree from The University of Arizona and immediately began his professional digital marketing career.

After successfully developing a strategy division with a startup hosting and graphic design company, Chad I Lieberman began pursuing the concept for the 6W Firm. His unique vision takes aspects of digital marketing, social, search and reputation, and integrates each equally into strategic monthly milestones.

Lieberman has a passion for teaching and presenting his expert knowledge of the digital marketing industry with other professionals and has presented for numerous corporate organizations, associations and workforces across United States of America.

"Chad Ian Lieberman" currently resides in New York City, and enjoys playing golf, chess, swimming, fishing, networking and reading. His passion for entrepreneurship has led to a number of promising side projects and partnerships. Learn more at http://www.6wim.com


Press release courtesy of Online PR Media: http://bit.ly/1L0tEgV

Tara Wolfe
Chad Lieberman 6W Marketing
212-600-0775
email us here